Unlock instant, AI-driven research and patent intelligence for your innovation.
Refining method of high-purity cariprazine
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A refining method and cariprazine technology, applied in the refining field of high-purity cariprazine, can solve problems such as by-product X being difficult to remove
Active Publication Date: 2020-06-23
NHWA PHARMA CORPORATION
View PDF5 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0014] In order to solve the problem that the by-product X in the prior art is difficult to remove, the present invention provides a method for refining cariprazine, so that impurities can be effectively removed before cariprazine is salified, and the product purity is improved
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
[0038] (2) Slowly add 75ml of ethyl acetate and stir for 20 minutes; slowly cool down to 30°C.
[0039] (3) Ice-water bath, cooled to 0-10°C, stirred for 3 hours;
[0040] (4) Filter, and wash the filter cake with 30ml ethyl acetate, and vacuum-dry to constant weight at 50°C to obtain 8.1g cariprazine crystals, yield 81%, purity (HPLC) 99.79, impurity X (63.78min) The content of 0.02%, such as figure 2 mentioned.
[0043] (2) Slowly add 75ml of ethyl acetate and stir for 20 minutes; slowly cool down to 30°C.
[0044] (3) Ice-water bath, cooled to 0-10°C, stirred for 5 hours;
[0045] (4) filter, and wash the filter cake with 15ml ethyl acetate, and vacuum-dry to constant weight at 50 ℃, obtain 8.4g cariprazine crystal, yield 84%, purity (HPLC) 99.68, impurity X (63.33min) The content of 0.04%, such as image 3 shown.
Embodiment 3
[0047] (1) Add 20 g of cariprazine crude product into a 500 ml reaction flask, add 40 ml of methylenechloride and 60 ml of ethanol, and heat to reflux to make the solution clear;
[0048] (2) Slowly add 100ml of ethyl acetate and stir for 20 minutes; slowly cool down to 30°C.
[0049] (3) Ice-water bath, cooled to 0-10°C, stirred for 3 hours;
[0050] (4) filter, and wash the filter cake with 30ml ethyl acetate, and vacuum-dry to constant weight at 50 ℃, obtain 17.1g cariprazine crystal, yield 85.5%, purity (HPLC) 99.88, the content of impurity X 0.02% ,Such as Figure 4 shown.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to a refining method of high-purity cariprazine. The refining method comprises the following steps: adding dichloromethane and alcohol into a cariprazine crude product, heating and stirring until the crude product is dissolved, adding an ester solvent or a ketonesolvent; cooling, crystallizing, filtering, collecting cariprazine crystals, washing cariprazine crystals by ethylacetate, and drying cariprazine crystals in vacuum to obtain high-purity cariprazine. According to the refining method, the yield of cariprazine is 80% or above, the purity (HPLC) reaches 99.5%, andthe impurity content is reduced to about 0.1%.
Description
technical field [0001] The invention belongs to the field of medicinal chemistry, in particular to a method for refining high-purity cariprazine. Background technique [0002] Cariprazinehydrochloride, chemical name trans-1-{4-[2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl]-cyclohexyl}- 3,3-Dimethylureahydrochloride, a D 2 and D 3 Receptor partial agonists, especially for D 3 Receptors have high selectivity for 5-HT 1A Also has partial agonism, co-developed by Gedeon Richter and Forest Laboratories. On September 17, 2015, the FDA approved it for the treatment of schizophrenia and bipolar disorder. [0003] The structure of cariprazine is shown below: [0004] [0005] The preparation method of cariprazine disclosed at home and abroad mainly contains 2 classes at present: [0006] (1) Patent CN1829703 reports 2,3-dichlorophenylpiperazine (VII) and trans-tert-butyl (4-(2-oxoethyl)cyclohexyl)ammoniumformate (X) as key intermediates , intermediate IX was obtained...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.